Hemolysis associated with pneumatic tube system transport for blood samples.
Hasan Kara, Aysegul Bayir, Ahmet Ak...
https://pubmed.ncbi.nlm.nih.gov/24639830/Actively Recruiting
Led by Marmara University Pendik Training and Research Hospital · Updated on 2026-09-23
166
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are evaluating whether transporting blood samples using a pneumatic tube system PTS impacts the hemolysis level compared to manual personnel transport in emergency department ED blood samples. Hemolysis, the breakdown of red blood cells, is a common error affecting lab results and diagnosis. This study uses a randomized, split-sample, single-blind design to compare two blood tubes drawn from the same patient but transported differently, eliminating biological variation between patients. Participants have two yellow-cap serum separator tubes drawn simultaneously during routine blood collection. One tube is randomly transported via the Sumetzberger Power Control pneumatic tube system, operating at 4-5 meters per second over 120 meters using cushioned capsules, taking 50 to 90 seconds. The other tube is manually carried by ED staff to the central lab. Allocation is balanced by tube order, and laboratory technicians analyzing hemolysis levels remain unaware of transport methods. During the study, participants provide blood samples as part of their usual care, with no additional procedures or risks. The primary outcome is the Hemolysis Index category measured in the laboratory within 30 minutes of blood draw. Secondary outcomes include rates of clinically significant hemolysis and the relationship between transport time and hemolysis. The study runs from September 2026 to January 2027, with no extra visits beyond routine care.
CONDITIONS
Pneumatic Tube System Versus Personnel Transport and the Hemolysis Index of Emergency Department Blood Samples: A Randomized, Split-Sample, Single-Blind Trial
E
Emir Ünal, Assistant Professor
E
Emir Ünal, Assistant Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Marmara University Pendik Training and Research Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single visit
Participants have two blood tubes drawn simultaneously during routine care. One tube is transported by the pneumatic tube system, and the other is carried manually by personnel to the laboratory.
1 visit (in-person)
Duration - Minutes after blood draw
The blood samples are analyzed within 30 minutes of collection to measure hemolysis levels, including the Hemolysis Index and clinically significant hemolysis.
No additional visits required
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Hasan Kara, Aysegul Bayir, Ahmet Ak...
https://pubmed.ncbi.nlm.nih.gov/24639830/Gokhan Cakirca, Huseyin Erdal
https://pubmed.ncbi.nlm.nih.gov/28359708/Xuemei Ding, Xiulin Wen, Liying Wang...
https://pubmed.ncbi.nlm.nih.gov/34109899/Michael P Phelan, Edmunds Z Reineks, Fredric M Hustey...
https://pubmed.ncbi.nlm.nih.gov/27625719/Garrett R Mullins, David E Bruns
https://pubmed.ncbi.nlm.nih.gov/28803746/Marmara University Pendik Training and Research Hospital
Lead Sponsor